Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.75 |
| ▸ | NPC1 | O15118 | 7/20 | 0.65 |
| ▸ | RAB9A | P51151 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 8/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.65 |
| ▸ | HPGD | P15428 | 5/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.65 |
| ▸ | CASP3 | P42574 | 1/20 | 0.65 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.65 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.65 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30137602 | 1.00 | MAOA (0.75) | MAOANPC1RAB9AMAPTKDM4E | |
| Nitrogen SCHEMBL8500849 | 0.96 | MAOA (0.71) | MAOANPC1RAB9AMAPTKDM4E | |
| Nitrogen SCHEMBL8498895 | 0.95 | MAOA (0.69) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL18045173 | 0.90 | ALDH1A1 (0.77) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL31260258 | 0.89 | MAOA (0.81) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL7107987 | 0.89 | MAOA (0.81) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL394209 | 0.86 | MAOA (1.00) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL30594702 | 0.86 | MAOA (0.58) | MAOANPC1RAB9AMAPTKDM4E | |
| SCHEMBL4393859 | 0.86 | MAOA (0.67) | MAOANPC1RAB9AMAPTKDM4E | |
| Nitrogen SCHEMBL8497934 | 0.85 | MAOA (0.76) | MAOANPC1RAB9AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115611918-B | Dibenzofurane-based binary-axis chiral organic circularly polarized phosphorescent compounds | 哈尔滨工业大学（深圳） | 2024-01-02 | — | — | CN | claimed |
| CN-105440185-B | A kind of loaded catalyst and preparation method thereof and its method for being used for propylene polymerization | 万华化学集团股份有限公司 | 2019-04-19 | — | — | CN | claimed |
| WO-2013091451-A1 | IMPROVER FOR VISBREAKING AND PROCESS FOR CO-VISBREAKING TO COAL TAR OR BIO-OIL CONTAINING THE SAME AND HEAVY OIL | SHENHUA GROUP CORPORATION LIMITED (CN) | 2013-06-27 | — | — | WO | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5958930-A | TREATING CANCER, AND SECONDARY INFECTIONS CAUSED BY PNEUMOCYSTIS CARINII AND TOXOPLASMOSIS GONDII IN IMMUNOCOMPROMISED PATIENTS. | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-09-28 | — | — | US | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| WO-2025202185-A1 | PROCESS FOR THE FUNCTIONALIZATION OF AN AROMATIC OR HETEROAROMATIC AMINO COMPOUND | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2025-10-02 | — | — | WO | disclosed |
| EP-4624456-A1 | PROCESS FOR THE DEAMINATIVE HALOGENATION OF AN AROMATIC OR HETEROAROMATIC AMINO COMPOUND | Studiengesellschaft Kohle gGmbH (DE) | 2025-10-01 | — | — | EP | disclosed |
| CN-115611918-B | Dibenzofurane-based binary-axis chiral organic circularly polarized phosphorescent compounds | 哈尔滨工业大学（深圳） | 2024-01-02 | — | — | CN | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| US-11563185-B2 | Heterocyclic compound and organic light-emitting device comprising same | LT MATERIALS CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| CN-111748370-B | Thermal modification method for heavy oil by aid of aid | 中国石油天然气股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-6027555-A | Hot melt ink compositions | XEROX CORPORATION (US) | 2000-02-22 | — | — | US | disclosed |
| US-5958119-A | Hot melt ink compositions | XEROX CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| US-5958930-A | TREATING CANCER, AND SECONDARY INFECTIONS CAUSED BY PNEUMOCYSTIS CARINII AND TOXOPLASMOSIS GONDII IN IMMUNOCOMPROMISED PATIENTS. | DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) | 1999-09-28 | — | — | US | disclosed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0903383-A1 | Hot melt ink compositions | Xerox Corporation (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| US-5451458-A | Electrography | XEROX CORPORATION (US) | 1995-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | MAOA 934/4885NPC1 4076/4885RAB9A 1362/4885 |
| US-11563185-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CYP1A1, CYP1B1 | MAOA 301/4885NPC1 2657/4885RAB9A 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.